ヘルスケア株
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3283 |  CLPT ClearPoint Neuro Inc. - Common Stock | 9.07 USD | -5.91% | -12.54% | -33.65% | -64.90% | 276.67 M USD | ||
| 3285 |  SRZN Surrozen, Inc. - Common Stock | 23.44 USD | -6.50% | -18.33% | +38.13% | +74.66% | 275.50 M USD | ||
| 3297 |  AGEN Agenus Inc. - Common Stock | 6.04 USD | -9.58% | -20.53% | -20.32% | +52.14% | 271.92 M USD | ||
| 3306 |  ANIK Anika Therapeutics Inc. - Common Stock | 19.98 USD | -3.43% | +2.30% | -4.99% | +97.04% | 267.39 M USD | ||
| 3307 |  ONMD OneMedNet Corp - Class A Common Stock | 4.51 USD | -5.05% | +7.38% | +535.21% | +78.26% | 267.38 M USD | ||
| 3311 |  INFU InfuSystems Holdings, Inc. Common Stock | 13.40 USD | -3.67% | -0.81% | +8.94% | +72.90% | 266.89 M USD | ||
| 3318 |  OCGN Ocugen, Inc. - Common Stock | 0.78 USD | -3.70% | -18.75% | -23.53% | -51.85% | 264.51 M USD | ||
| 3326 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 2.06 USD | -4.63% | -5.07% | +112.37% | +101.96% | 262.15 M USD | ||
| 3333 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 3.26 USD | -1.81% | -16.62% | -28.82% | +178.63% | 260.16 M USD | ||
| 3336 |  EYPT EyePoint, Inc. - Common Stock | 2.99 USD | -4.78% | -12.57% | -24.30% | -75.08% | 257.77 M USD | ||
| 3339 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 2.59 USD | -1.89% | -10.38% | -25.57% | -12.79% | 256.79 M USD | ||
| 3344 |  ABEO Abeona Therapeutics Inc. - Common Stock | 4.43 USD | -4.73% | -10.14% | -24.14% | -19.16% | 253.33 M USD | ||
| 3350 |  TMCI Treace Medical Concepts, Inc. - Common Stock | 3.87 USD | -6.07% | -2.03% | -15.32% | -40.28% | 251.68 M USD | ||
| 3355 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 0.99 USD | 0.00% | +1.02% | -3.88% | -42.44% | 250.38 M USD | ||
| 3358 |  BDSX Biodesix, Inc. - Common Stock | 23.66 USD | -4.25% | -9.07% | -17.04% | +89.13% | 249.64 M USD | ||
| 3360 |  OSUR OraSure Technologies, Inc. - Common Stock | 3.61 USD | -5.25% | -7.44% | +3.44% | +17.59% | 248.98 M USD | ||
| 3365 |  IPSC Century Therapeutics, Inc. - Common Stock | 1.37 USD | -8.67% | -6.80% | -27.13% | +149.09% | 248.07 M USD | ||
| 3366 |  CATX Perspective Therapeutics, Inc. Common Stock | 2.17 USD | -7.66% | -18.73% | -25.17% | -50.68% | 247.71 M USD | ||
| 3367 |  LAB Standard BioTools Inc. - Common Stock | 0.63 USD | -4.55% | -7.35% | -12.50% | -50.39% | 247.32 M USD | ||
| 3370 |  PALI Palisade Bio, Inc. - Common Stock | 1.41 USD | -8.44% | -7.84% | -16.07% | -17.06% | 245.72 M USD |
ニュース ヘルスケア株
金曜日の取引時間中に動いたヘルスケア株12銘柄
ウィリアム・ブレア、IDEAYAバイオサイエンシズのカバレッジを開始し、アウトパフォーム評価を付与
レベレーション・バイオサイエンシズ、10月20日付で1対7の株式併合を発表
Gate、NeoSoul（DNA）の契約・レバレッジ・スワップ・コピートレードなど複数サービスを上場
Curis、1,666万6,000株の普通株式とワラントを1株当たり0.51ドルで約850万ドル規模で募集開始
タンゴ・セラピューティクス、ESMO Congress 2026において、MTAPdel/RASmut転移性膵管腺癌（PDAC）および非小細胞肺癌（NSCLC）患者を対象とした、ボピメトスタットとダラキソンラシブまたはゾルドンラシブの併用による第1/2相試験の最新データを発表へ
Fractyl HealthのREMAIN-1試験、6カ月の共同主要評価項目を高い統計学的有意性で達成；GLP-1誘導による減量の80%を維持し、シャム群の67%を上回ることを示す
上昇銘柄ヘルスケア株
 NXGLW NexGel, Inc - Warrant | 0.0099 | +52.31% |
 CTSO Cytosorbents Corporation - Common Stock | 4.11 | +34.31% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 0.61 | +22.00% |
 TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.63 | +20.64% |
 REVBW Revelation Biosciences, Inc. - Warrant | 0.0075 | +17.19% |
 CDT CDT Equity Inc. - Common Stock | 0.24 | +14.29% |
 MRKR Marker Therapeutics, Inc. - Common Stock | 1.04 | +13.04% |
 CVKD Cadrenal Therapeutics, Inc. - Common Stock | 1.09 | +12.37% |
下落銘柄ヘルスケア株
 BEATW Heartbeam, Inc. - Warrant | 0.0031 | -65.56% |
 MDXH MDxHealth SA - American Depositary Shares | 0.21 | -65.00% |
 GUTS Fractyl Health, Inc. - Common Stock | 1.55 | -62.74% |
 REVB Revelation Biosciences, Inc. - Common Stock | 0.48 | -36.84% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 MBRX Moleculin Biotech, Inc. - Common Stock | 0.28 | -24.32% |
 JAGX Jaguar Health, Inc. - Common Stock | 3.53 | -23.09% |
 SLXN Silexion Therapeutics Corp - Ordinary Shares | 0.15 | -21.05% |